Michael K Wendt

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 25

Top Venues

Molecular cancer research : MCR

Communications biology

Oncogene

Cancers

Purdue University

Medical College of Wisconsin (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Purdue University Aug 12 2019

United States

Associate Professor :: Molecular Pharmacology

Purdue University Jan 01 2014 - Aug 11 2019

United States

Assistant Professor :: Molecular Pharmacology

Case Western Reserve University School of Medicine

United States

Post Doc :: Basic Medicinal Sciences; Oncology

University of Colorado Denver

United States

Post Doc :: Pharmacology

Education History

Medical College of Wisconsin

United States

PHD :: Microbiology and Molecular Genetics

St. Norbert College

United States

BSC

Publications

Eylem Kulkoyluoglu Cotul, Muhammad Hassan Safdar, Sebastian Juan Paez, Aneesha Kulkarni, Mitchell G Ayers, Hang Lin, Zilin Xianyu, Dorothy Teegarden, Stephen D Hursting, Michael K Wendt
FGFR1 Signaling Facilitates Obesity-Driven Pulmonary Outgrowth in Metastatic Breast Cancer. Molecular cancer research : MCR 22 (3) (2024)
Eylem Kulkoyluoglu Cotul, Muhammad Hassan Safdar, Sebastian Juan Paez, Aneesha Kulkarni, Mitchell G Ayers, Hang Lin, Zilin Xianyu, Dorothy Teegarden, Stephen D Hursting, Michael K Wendt
FGFR1 Signaling Facilitates Obesity-Driven Pulmonary Outgrowth in Metastatic Breast Cancer. Molecular cancer research : MCR 22 (3) (2024)
Hang Lin, Muhammad Hassan Safdar, Sarah Washburn, Saeed S Akhand, Jonathan Dickerhoff, Mitchell Ayers, Marvis Monteiro, Luis Solorio, Danzhou Yang, Michael K Wendt
Fibroblast growth receptor 1 is regulated by G-quadruplex in metastatic breast cancer. Communications biology 7 (1) (2024)
Hang Lin, Muhammad Hassan Safdar, Sarah Washburn, Saeed S Akhand, Jonathan Dickerhoff, Mitchell Ayers, Marvis Monteiro, Luis Solorio, Danzhou Yang, Michael K Wendt
Fibroblast growth receptor 1 is regulated by G-quadruplex in metastatic breast cancer. Communications biology 7 (1) (2024)
Eylem Kulkoyluoglu Cotul, Muhammad Hassan Safdar, Sebastian Juan Paez, Aneesha Kulkarni, Mitchell G Ayers, Hang Lin, Zilin Xianyu, Dorothy Teegarden, Stephen D Hursting, Michael K Wendt
FGFR1 Signaling Facilitates Obesity-Driven Pulmonary Outgrowth in Metastatic Breast Cancer. Molecular cancer research : MCR 22 (3) (2024)
Hang Lin, Muhammad Hassan Safdar, Sarah Washburn, Saeed S Akhand, Jonathan Dickerhoff, Mitchell Ayers, Marvis Monteiro, Luis Solorio, Danzhou Yang, Michael K Wendt
Fibroblast growth receptor 1 is regulated by G-quadruplex in metastatic breast cancer. Communications biology 7 (1) (2024)
Eylem Kulkoyluoglu Cotul, Muhammad Hassan Safdar, Sebastian Juan Paez, Aneesha Kulkarni, Mitchell G Ayers, Hang Lin, Zilin Xianyu, Dorothy Teegarden, Stephen D Hursting, Michael K Wendt
FGFR1 Signaling Facilitates Obesity-Driven Pulmonary Outgrowth in Metastatic Breast Cancer. Molecular cancer research : MCR 22 (3) (2024)
Eylem Kulkoyluoglu Cotul, Muhammad Hassan Safdar, Sebastian Juan Paez, Aneesha Kulkarni, Mitchell G Ayers, Hang Lin, Zilin Xianyu, Dorothy Teegarden, Stephen D Hursting, Michael K Wendt
FGFR1 Signaling Facilitates Obesity-Driven Pulmonary Outgrowth in Metastatic Breast Cancer. Molecular cancer research : MCR 22 (3) (2024)
Hang Lin, Muhammad Hassan Safdar, Sarah Washburn, Saeed S Akhand, Jonathan Dickerhoff, Mitchell Ayers, Marvis Monteiro, Luis Solorio, Danzhou Yang, Michael K Wendt
Fibroblast growth receptor 1 is regulated by G-quadruplex in metastatic breast cancer. Communications biology 7 (1) (2024)
Ammara Abdullah, Saeed Salehin Akhand, Juan Sebastian Paez Paez, Wells Brown, Li Pan, Sarah Libring, Michael Badamy, Emily C Dykhuizen, Luis Solorio, Weiguo Andy Tao, Michael K Wendt
Correction: Epigenetic targeting of neuropilin-1 prevents bypass signaling in drug-resistant breast cancer. Oncogene (2023)
Eylem Kulkoyluoglu Cotul, Muhammad Hassan Safdar, Sebastian Juan Paez, Aneesha Kulkarni, Mitchell G Ayers, Hang Lin, Zilin Xianyu, Dorothy Teegarden, Stephen D Hursting, Michael K Wendt
FGFR1 signaling facilitates obesity-driven pulmonary outgrowth in metastatic breast cancer. Molecular cancer research : MCR (2023)
Eylem Kulkoyluoglu Cotul, Muhammad Hassan Safdar, Sebastian Juan Paez, Aneesha Kulkarni, Mitchell G Ayers, Hang Lin, Zilin Xianyu, Dorothy Teegarden, Stephen D Hursting, Michael K Wendt
FGFR1 signaling facilitates obesity-driven pulmonary outgrowth in metastatic breast cancer. Molecular cancer research : MCR (2023)
Violet A Kiesel, Madeline P Sheeley, Shawn S Donkin, Michael K Wendt, Stephen D Hursting, Dorothy Teegarden
Increased Ammonium Toxicity in Response to Exogenous Glutamine in Metastatic Breast Cancer Cells. Metabolites 12 (5) (2022)
Hao Chen, Gregory M Cresswell, Sarah Libring, Mitchell G Ayers, Jinmin Miao, Zhong-Yin Zhang, Luis Solorio, Timothy L Ratliff, Michael K Wendt
Tumor Cell-Autonomous SHP2 Contributes to Immune Suppression in Metastatic Breast Cancer. Cancer research communications 2 (10) (2022)
Jennifer R Diamond, Todd M Pitts, Dana Ungermannova, Christopher G Nasveschuk, Gan Zhang, Andrew J Phillips, Stacey M Bagby, Jessica Pafford, Betelehem W Yacob, Timothy P Newton, John J Tentler, Brian Gittleman, Sarah J Hartman, John A DeMattei, James D Winkler, Michael K Wendt, William P Schiemann, S Gail Eckhardt, Xuedong Liu, Anthony D Piscopio
Preclinical Development of the Class-I-Selective Histone Deacetylase Inhibitor OKI-179 for the Treatment of Solid Tumors. Molecular cancer therapeutics 21 (3) (2022)
Hao Chen, Gregory M Cresswell, Sarah Libring, Mitchell G Ayers, Jinmin Miao, Zhong-Yin Zhang, Luis Solorio, Timothy L Ratliff, Michael K Wendt
Tumor Cell-Autonomous SHP2 Contributes to Immune Suppression in Metastatic Breast Cancer. Cancer research communications 2 (10) (2022)
Aaron D Krabill, Hao Chen, Sajjad Hussain, Chad S Hewitt, Ryan D Imhoff, Christine S Muli, Chittaranjan Das, Paul J Galardy, Michael K Wendt, Daniel P Flaherty
Optimization and Anti-Cancer Properties of Fluoromethylketones as Covalent Inhibitors for Ubiquitin C-Terminal Hydrolase L1. Molecules (Basel, Switzerland) 26 (5) (2021)
Saeed S Akhand, Hao Chen, Stephen Connor Purdy, Zian Liu, Joshua C Anderson, Christopher D Willey, Michael K Wendt
Fibroblast growth factor receptor facilitates recurrence of minimal residual disease following trastuzumab emtansine therapy. NPJ breast cancer 7 (1) (2021)
Ammara Abdullah, Saeed Salehin Akhand, Juan Sebastian Paez Paez, Wells Brown, Li Pan, Sarah Libring, Michael Badamy, Emily C Dykhuizen, Luis Solorio, Weiguo Andy Tao, Michael K Wendt
Epigenetic targeting of neuropilin-1 prevents bypass signaling in drug-resistant breast cancer. Oncogene 40 (2) (2020)
Brian H Jun, Tianqi Guo, Sarah Libring, Monica K Chanda, Juan Sebastian Paez, Aparna Shinde, Michael K Wendt, Pavlos P Vlachos, Luis Solorio
Fibronectin-Expressing Mesenchymal Tumor Cells Promote Breast Cancer Metastasis. Cancers 12 (9) (2020)
Aparna Shinde, Juan Sebastian Paez, Sarah Libring, Kelsey Hopkins, Luis Solorio, Michael K Wendt
Transglutaminase-2 facilitates extracellular vesicle-mediated establishment of the metastatic niche. Oncogenesis 9 (2) (2020)
Sarah Libring, Aparna Shinde, Monica K Chanda, Maryam Nuru, Heather George, Aya M Saleh, Ammara Abdullah, Tamara L Kinzer-Ursem, Sarah Calve, Michael K Wendt, Luis Solorio
The Dynamic Relationship of Breast Cancer Cells and Fibroblasts in Fibronectin Accumulation at Primary and Metastatic Tumor Sites. Cancers 12 (5) (2020)
Hao Chen, Sarah Libring, Kasi Viswanatharaju Ruddraraju, Jinmin Miao, Luis Solorio, Zhong-Yin Zhang, Michael K Wendt
SHP2 is a multifunctional therapeutic target in drug resistant metastatic breast cancer. Oncogene 39 (49) (2020)
Aparna Shinde, Tomasz Wilmanski, Hao Chen, Dorothy Teegarden, Michael K Wendt
Pyruvate carboxylase supports the pulmonary tropism of metastatic breast cancer. Breast cancer research : BCR 20 (1) (2018)
Remah Ali, Wells Brown, Stephen Connor Purdy, Vincent Jo Davisson, Michael K Wendt
Biased signaling downstream of epidermal growth factor receptor regulates proliferative versus apoptotic response to ligand. Cell death & disease 9 (10) (2018)

Michael K Wendt.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Michael K Wendt